Arrowhead Pharmaceuticals, Inc(NASDAQ:ARWR) 
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated wi...
Website: http://arrowheadpharma.com
Founded: 1989
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 11.74
H 11.96
L 10.65
C 10.68
V 2,565,519
10EMA 10.68
20EMA 10.68
60EMA 10.68
120EMA 10.68
250EMA 10.68